Unknown

Dataset Information

Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States.


ABSTRACT: Prostate cancer represents the most frequent tumor in men, accounting for the 21% of all diagnosed tumors, with 191,930 new cases and 33,330 deaths estimated in 2020. Advanced prostate cancer represents a heterogeneous disease, ranging from hormone naive or hormone sensitive to castration resistant. The therapeutic armamentarium for this disease has been implemented in the last years by novel hormonal therapies and chemotherapies. However, the percentage of patients who achieve complete responses still results negligible. On this scenario, the design of clinical trials investigating new therapeutic approaches represent a dramatic medical need. Predicting cancer incidence may be fundamental to design specific clinical trials, to optimize the allocation of economic resources, and to plan fut

SUBMITTER: Santoni M 

PROVIDER: S-EPMC8039584 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature